Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
RND
Upturn stock rating

First Trust Bloomberg R&D Leaders ETF (RND)

Upturn stock rating
$30.37
Last Close (24-hour delay)
Profit since last BUY23.81%
upturn advisory
Consider higher Upturn Star rating
BUY since 116 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

10/24/2025: RND (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Analysis of Past Performance

Type ETF
Historic Profit 29.81%
Avg. Invested days 112
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance 5.0
ETF Returns Performance Upturn Returns Performance 4.0
Upturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulation Last Close 10/24/2025

Key Highlights

Volume (30-day avg) -
Beta -
52 Weeks Range 19.84 - 26.69
Updated Date 06/30/2025
52 Weeks Range 19.84 - 26.69
Updated Date 06/30/2025

ai summary icon Upturn AI SWOT

First Trust Bloomberg R&D Leaders ETF

stock logo

ETF Overview

overview logo Overview

The First Trust Bloomberg R&D Leaders ETF (EFIV) seeks to track the investment results of an index composed of U.S. companies that demonstrate leadership in research and development (R&D) spending. It targets the broad market with a focus on innovation and growth.

reliability logo Reputation and Reliability

First Trust is a well-established ETF provider with a solid reputation for offering innovative investment solutions.

reliability logo Management Expertise

First Trust has a team of experienced investment professionals dedicated to managing and monitoring their ETF offerings.

Investment Objective

overview logo Goal

The ETF aims to provide investment results that correspond generally to the price and yield of the Bloomberg U.S. Investment Grade Corporate Bond Index.

Investment Approach and Strategy

Strategy: The ETF tracks the Bloomberg U.S. R&D Leaders Index, which identifies companies with significant R&D spending.

Composition The ETF holds stocks of U.S. companies across various sectors, weighted based on their R&D expenditure.

Market Position

Market Share: EFIV's market share in the innovation-focused ETF space is moderate, competing with broader technology and growth ETFs.

Total Net Assets (AUM): 315840000

Competitors

overview logo Key Competitors

  • ARK Innovation ETF (ARKK)
  • SPDR S&P Biotech ETF (XBI)
  • Invesco QQQ Trust (QQQ)

Competitive Landscape

The competitive landscape is dominated by larger, more established innovation and technology ETFs. EFIV distinguishes itself with its specific focus on R&D spending as a selection criterion. However, ARKK and QQQ are much larger and offer broader exposure, while XBI focuses on the biotechnology sector. EFIV offers more targeted approach to identifying innovative companies compared to broader growth ETFs but faces competition from sector-specific funds like XBI.

Financial Performance

Historical Performance: Historical performance data is available from financial data providers and should be reviewed for various time periods.

Benchmark Comparison: The ETF's performance should be compared to the Bloomberg U.S. R&D Leaders Index to assess its tracking effectiveness.

Expense Ratio: 0.0058

Liquidity

Average Trading Volume

The ETF's average daily trading volume is moderate, indicating reasonable liquidity.

Bid-Ask Spread

The bid-ask spread is typically tight, which helps minimize trading costs for investors.

Market Dynamics

Market Environment Factors

Economic indicators, technological advancements, and government policies related to R&D can impact the ETF's performance.

Growth Trajectory

The ETF's growth trajectory is tied to the performance of its underlying holdings and the overall health of the R&D-intensive sectors.

Moat and Competitive Advantages

Competitive Edge

EFIV's unique selection methodology based on R&D spending provides a distinct competitive advantage by focusing on companies committed to innovation. This focus allows investors to target firms that are actively investing in their future growth. The fund's weighting methodology also contributes to its distinct profile, potentially leading to different performance outcomes compared to broader tech or growth ETFs. First Trust's expertise in developing thematic ETFs further bolsters its competitive positioning in the market.

Risk Analysis

Volatility

The ETF's volatility is expected to be moderate to high, given its exposure to growth-oriented companies.

Market Risk

Market risk is a primary concern, as the ETF's performance is susceptible to overall market fluctuations and sector-specific downturns.

Investor Profile

Ideal Investor Profile

The ideal investor is someone seeking exposure to innovative companies and willing to accept moderate to high risk for potential long-term growth.

Market Risk

The ETF is best suited for long-term investors with a growth-oriented investment strategy.

Summary

The First Trust Bloomberg R&D Leaders ETF (EFIV) offers a targeted approach to investing in companies with high R&D spending. Its focus on innovation can provide growth potential, but also carries risks associated with technology and growth stocks. The ETF is well-suited for long-term investors seeking exposure to innovation. Investors should consider the fund's specific methodology and compare it to broader market and technology ETFs. Performance should be compared to the Bloomberg R&D Leaders Index to evaluate tracking effectiveness.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • First Trust
  • Bloomberg
  • Yahoo Finance
  • ETFdb.com
  • Morningstar

Disclaimers:

This data is for informational purposes only and should not be considered investment advice. Past performance is not indicative of future results. Consult with a qualified financial advisor before making any investment decisions.

Upturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About First Trust Bloomberg R&D Leaders ETF

Exchange NYSE ARCA
Headquaters -
IPO Launch date -
CEO -
Sector -
Industry -
Full time employees -
Website
Full time employees -
Website

Under normal market conditions, the fund will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the securities that comprise the index. According to the index provider, the index is designed to track the performance of companies that seek to return implicit value to shareholders by reinvesting in their own growth. The fund is non-diversified.